Sandoz Group (SDZ.SW) Stock Price

Sandoz Group Price

SIX·CLOSED
90.35
​
Market closed

Revenue has compounded at 5.5% per year over the past 5 years to 11.16 B USD. Earnings per share have grown at 18.2% per year over the last 5 years. Sandoz Group's net margin stands at 8.6%, broadly stable from 9.4% several years earlier. Sandoz Group currently offers a dividend yield of about 0.66%. The payout ratio is around 33% of earnings. Analysts set a median price target of 66.07 USD, implying 26.9% below the current price. Of 20 analysts, 11 rate the stock a buy — an overall Buy consensus.

Sandoz Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sandoz Group business model & stock analysis

Sandoz Group AG is a pharmaceutical company headquartered in Rotkreuz, Switzerland. It operates in the healthcare sector, specifically within the pharmaceuticals industry. The company went public on October 4, 2023, with its ticker listed as SDZ.SW and ISIN CH1243598427. Sandoz Group AG focuses on two primary business areas: Generics and Biosimilars. The Generics division develops, manufactures, and markets active ingredients and finished dosage forms of small molecule pharmaceuticals, as well as anti-infective finished dosage forms and active pharmaceutical ingredients. The Biosimilars division develops, manufactures, and markets protein-based and other biological products that are similar to already approved biological medicines. The company's product portfolio spans multiple therapeutic areas, including cardiovascular, central nervous system, oncology, anti-infectives, pain, and respiratory conditions. Sandoz Group AG serves customers globally, providing pharmaceutical solutions across various medical fields. The company is based in Switzerland and operates within the pharmaceuticals industry, with its headquarters located in Rotkreuz. It is active in the healthcare technology industry, though specific details about its technology focus are not provided. The company's operations are centered around the development and distribution of generic and biosimilar medications to meet global healthcare needs.

Frequently asked questions about Sandoz Group

Analysts currently set an average price target of 67.42 USD for the Sandoz Group stock (median: 66.07 USD), implying -25.4 % versus the latest price. The consensus is based on 20 analyst ratings.

20 analysts currently rate the Sandoz Group stock: 11 recommend buying, 8 holding and 1 selling. For 2026, analysts expect Sandoz Group to generate revenue of 12.53 B USD and earnings per share of 4.22 USD.

Converted at the current exchange rate, the Sandoz Group share trades at 80.56 EUR (90.35 USD).

The Sandoz Group share (SDZ.SW) is listed on 3 stock exchanges, including: London (0SAN.L), SIX (Zürich) (SDZ.SW).

The expected revenue of Sandoz Group is 12.53 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Sandoz Group is 1.85 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Sandoz Group is currently 21.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sandoz Group stock.

The price-to-sales ratio (P/S) of Sandoz Group is currently 3.15. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sandoz Group stock.

The Eulerpool Quality Score for Sandoz Group is 4/10.

The ISIN of Sandoz Group is CH1243598427. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sandoz Group is SDZ.SW. The ticker symbol is used to trade Sandoz Group shares on the stock exchange.

Fair ValueTerminal
82.22 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
Oct 4, 2023
ISIN
CH1243598427
Cusip
H7140B103
Market capitalization
39.76 B USDLarge Cap
52-Week Range
PEG
4.43
P/E ratio
P/Ee 2026
21.51
P/Ee 2027
19.13
P/Ee 2028
17.12
P/Ee 2029
15.35
P/Ee 2030
13.77
P/S
P/Se
3.15
EV/EBIT
30.67
P/B Ratio
4.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.35 %
Dividend
Dividend yield
0.66 %
Est. Dividend Yield
0.80 %
Payout Ratio
32.89 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
2 years
Dividend increased since
2 years
Dividend withholding tax
35.00 %
Last updated Oct 16, 2026, 4:14 AM

Sandoz Group Peer Group

Sandoz Group Ticker

LONDON · 0SAN.LLONDON STOCK EXCHANGE · 0SAN.LSIX · SDZ.SW

Sandoz Group FIGI

SDZ:SW · BBG01J3DD3T3SDZ:SE · BBG01J3DD3W9SDZ:BW · BBG01J3DD402SDZXF:US · BBG01JLX0359SDZXF:PQ · BBG01JLX03N9SDZXF:UV · BBG01JLX03P7SDZZ:S1 · BBG01JM5FFK9SDZCHF:EP · BBG01JM5MZL6SDZCHF:EZ · BBG01JM5MZP2SDZCHF:EO · BBG01JM5MZQ1SDZCHF:X2 · BBG01JM5MZR0SDZCHF:XH · BBG01JM5MZT8

All fundamentals and in-depth analysis of Sandoz Group

Our stock analysis for Sandoz Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sandoz Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.